8-K
Current Report
NRX Pharmaceuticals, Inc. Filed Acc 0001558370-22-001035
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading nrxp-20220211x8k.htm…